Remdesivir had been the first medication to be approved by the U.S. FDA for Emergency Use Authorization (EUA) for the treatment of adult and pediatric patients with suspected or laboratory-confirmed SARS-CoV-2 infection and severe COVID-19. Also, it became the first medicine against COVID-19 to be recommended for authorization in the EU by the EMA.
(Favipiravir 200 mg) The Japanese antiviral Avigan, which is used to treat severe influenza, respiratory viruses, and mild to moderate COVID-19 patients.
(Oseltamivir 75mg), it provides support with suspected COVID-19 patients during the Influenza season.
(Hydroxychloroquine sulfate 200 mg) is an antiviral product for the treatment of uncomplicated malaria. Also, it can be prescribed for the treatment of mild and moderate COVID-19 cases as per Egyptian protocol for COVID-19 management.
Dose: 400 mg “two tablets” twice on the first day then 200 mg “one tablet” twice for 6 days.
